nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—ACE—psoriatic arthritis	0.914	1	CbGaD
Quinapril—Perindopril—ACE—psoriatic arthritis	0.00105	0.128	CrCbGaD
Quinapril—Spirapril—ACE—psoriatic arthritis	0.00104	0.126	CrCbGaD
Quinapril—Moexipril—ACE—psoriatic arthritis	0.000999	0.121	CrCbGaD
Quinapril—Cilazapril—ACE—psoriatic arthritis	0.000929	0.113	CrCbGaD
Quinapril—Lisinopril—ACE—psoriatic arthritis	0.000929	0.113	CrCbGaD
Quinapril—Trandolapril—ACE—psoriatic arthritis	0.0009	0.109	CrCbGaD
Quinapril—Ramipril—ACE—psoriatic arthritis	0.0009	0.109	CrCbGaD
Quinapril—Benazepril—ACE—psoriatic arthritis	0.000808	0.0981	CrCbGaD
Quinapril—Enalapril—ACE—psoriatic arthritis	0.000682	0.0827	CrCbGaD
Quinapril—Arrhythmia—Betamethasone—psoriatic arthritis	0.000244	0.00315	CcSEcCtD
Quinapril—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000244	0.00315	CcSEcCtD
Quinapril—Pancreatitis—Methotrexate—psoriatic arthritis	0.000243	0.00315	CcSEcCtD
Quinapril—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000243	0.00314	CcSEcCtD
Quinapril—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000243	0.00313	CcSEcCtD
Quinapril—Alopecia—Dexamethasone—psoriatic arthritis	0.000241	0.00312	CcSEcCtD
Quinapril—Alopecia—Betamethasone—psoriatic arthritis	0.000241	0.00312	CcSEcCtD
Quinapril—Discomfort—Prednisolone—psoriatic arthritis	0.00024	0.0031	CcSEcCtD
Quinapril—Angioedema—Triamcinolone—psoriatic arthritis	0.000239	0.00309	CcSEcCtD
Quinapril—Angioedema—Methylprednisolone—psoriatic arthritis	0.000239	0.00309	CcSEcCtD
Quinapril—Malaise—Triamcinolone—psoriatic arthritis	0.000236	0.00305	CcSEcCtD
Quinapril—Malaise—Methylprednisolone—psoriatic arthritis	0.000236	0.00305	CcSEcCtD
Quinapril—Vertigo—Triamcinolone—psoriatic arthritis	0.000235	0.00304	CcSEcCtD
Quinapril—Syncope—Triamcinolone—psoriatic arthritis	0.000235	0.00304	CcSEcCtD
Quinapril—Vertigo—Methylprednisolone—psoriatic arthritis	0.000235	0.00303	CcSEcCtD
Quinapril—Syncope—Methylprednisolone—psoriatic arthritis	0.000234	0.00303	CcSEcCtD
Quinapril—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000234	0.00302	CcSEcCtD
Quinapril—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000233	0.003	CcSEcCtD
Quinapril—Oedema—Prednisolone—psoriatic arthritis	0.000233	0.003	CcSEcCtD
Quinapril—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00023	0.00298	CcSEcCtD
Quinapril—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00023	0.00297	CcSEcCtD
Quinapril—Shock—Prednisolone—psoriatic arthritis	0.000229	0.00296	CcSEcCtD
Quinapril—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000229	0.00295	CcSEcCtD
Quinapril—Cough—Triamcinolone—psoriatic arthritis	0.000229	0.00295	CcSEcCtD
Quinapril—Tachycardia—Prednisolone—psoriatic arthritis	0.000227	0.00293	CcSEcCtD
Quinapril—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000227	0.00293	CcSEcCtD
Quinapril—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000225	0.0029	CcSEcCtD
Quinapril—Myalgia—Triamcinolone—psoriatic arthritis	0.000223	0.00288	CcSEcCtD
Quinapril—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000223	0.00288	CcSEcCtD
Quinapril—Myalgia—Methylprednisolone—psoriatic arthritis	0.000223	0.00288	CcSEcCtD
Quinapril—Eye disorder—Prednisone—psoriatic arthritis	0.000222	0.00287	CcSEcCtD
Quinapril—Infestation NOS—Methotrexate—psoriatic arthritis	0.000221	0.00286	CcSEcCtD
Quinapril—Infestation—Methotrexate—psoriatic arthritis	0.000221	0.00286	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000221	0.00286	CcSEcCtD
Quinapril—Depression—Methotrexate—psoriatic arthritis	0.000221	0.00285	CcSEcCtD
Quinapril—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000221	0.00285	CcSEcCtD
Quinapril—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000221	0.00285	CcSEcCtD
Quinapril—Discomfort—Triamcinolone—psoriatic arthritis	0.00022	0.00285	CcSEcCtD
Quinapril—Discomfort—Methylprednisolone—psoriatic arthritis	0.00022	0.00284	CcSEcCtD
Quinapril—Dry mouth—Triamcinolone—psoriatic arthritis	0.000218	0.00282	CcSEcCtD
Quinapril—Renal failure—Methotrexate—psoriatic arthritis	0.000218	0.00281	CcSEcCtD
Quinapril—Angioedema—Betamethasone—psoriatic arthritis	0.000217	0.00281	CcSEcCtD
Quinapril—Angioedema—Dexamethasone—psoriatic arthritis	0.000217	0.00281	CcSEcCtD
Quinapril—Angiopathy—Prednisone—psoriatic arthritis	0.000216	0.00279	CcSEcCtD
Quinapril—Immune system disorder—Prednisone—psoriatic arthritis	0.000215	0.00278	CcSEcCtD
Quinapril—Malaise—Betamethasone—psoriatic arthritis	0.000214	0.00277	CcSEcCtD
Quinapril—Malaise—Dexamethasone—psoriatic arthritis	0.000214	0.00277	CcSEcCtD
Quinapril—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000214	0.00276	CcSEcCtD
Quinapril—Oedema—Triamcinolone—psoriatic arthritis	0.000214	0.00276	CcSEcCtD
Quinapril—Vertigo—Betamethasone—psoriatic arthritis	0.000214	0.00276	CcSEcCtD
Quinapril—Vertigo—Dexamethasone—psoriatic arthritis	0.000214	0.00276	CcSEcCtD
Quinapril—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000213	0.00276	CcSEcCtD
Quinapril—Syncope—Dexamethasone—psoriatic arthritis	0.000213	0.00275	CcSEcCtD
Quinapril—Syncope—Betamethasone—psoriatic arthritis	0.000213	0.00275	CcSEcCtD
Quinapril—Arrhythmia—Prednisone—psoriatic arthritis	0.000212	0.00275	CcSEcCtD
Quinapril—Infection—Triamcinolone—psoriatic arthritis	0.000212	0.00274	CcSEcCtD
Quinapril—Infection—Methylprednisolone—psoriatic arthritis	0.000212	0.00274	CcSEcCtD
Quinapril—Shock—Triamcinolone—psoriatic arthritis	0.00021	0.00272	CcSEcCtD
Quinapril—Insomnia—Prednisolone—psoriatic arthritis	0.00021	0.00272	CcSEcCtD
Quinapril—Alopecia—Prednisone—psoriatic arthritis	0.00021	0.00272	CcSEcCtD
Quinapril—Shock—Methylprednisolone—psoriatic arthritis	0.00021	0.00271	CcSEcCtD
Quinapril—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000209	0.00271	CcSEcCtD
Quinapril—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000209	0.0027	CcSEcCtD
Quinapril—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000209	0.0027	CcSEcCtD
Quinapril—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000209	0.0027	CcSEcCtD
Quinapril—Paraesthesia—Prednisolone—psoriatic arthritis	0.000209	0.0027	CcSEcCtD
Quinapril—Tachycardia—Triamcinolone—psoriatic arthritis	0.000209	0.0027	CcSEcCtD
Quinapril—Mental disorder—Prednisone—psoriatic arthritis	0.000208	0.00269	CcSEcCtD
Quinapril—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000208	0.00269	CcSEcCtD
Quinapril—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000207	0.00268	CcSEcCtD
Quinapril—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000207	0.00267	CcSEcCtD
Quinapril—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000207	0.00267	CcSEcCtD
Quinapril—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000206	0.00266	CcSEcCtD
Quinapril—Myalgia—Betamethasone—psoriatic arthritis	0.000202	0.00261	CcSEcCtD
Quinapril—Myalgia—Dexamethasone—psoriatic arthritis	0.000202	0.00261	CcSEcCtD
Quinapril—Discomfort—Betamethasone—psoriatic arthritis	0.0002	0.00258	CcSEcCtD
Quinapril—Discomfort—Dexamethasone—psoriatic arthritis	0.0002	0.00258	CcSEcCtD
Quinapril—Hepatitis—Methotrexate—psoriatic arthritis	0.000199	0.00257	CcSEcCtD
Quinapril—Pharyngitis—Methotrexate—psoriatic arthritis	0.000197	0.00255	CcSEcCtD
Quinapril—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000196	0.00254	CcSEcCtD
Quinapril—Urethral disorder—Methotrexate—psoriatic arthritis	0.000195	0.00252	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000195	0.00252	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000194	0.00251	CcSEcCtD
Quinapril—Oedema—Betamethasone—psoriatic arthritis	0.000194	0.00251	CcSEcCtD
Quinapril—Oedema—Dexamethasone—psoriatic arthritis	0.000194	0.00251	CcSEcCtD
Quinapril—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000194	0.00251	CcSEcCtD
Quinapril—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000194	0.00251	CcSEcCtD
Quinapril—Insomnia—Triamcinolone—psoriatic arthritis	0.000193	0.0025	CcSEcCtD
Quinapril—Insomnia—Methylprednisolone—psoriatic arthritis	0.000193	0.00249	CcSEcCtD
Quinapril—Infection—Betamethasone—psoriatic arthritis	0.000193	0.00249	CcSEcCtD
Quinapril—Infection—Dexamethasone—psoriatic arthritis	0.000193	0.00249	CcSEcCtD
Quinapril—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000192	0.00248	CcSEcCtD
Quinapril—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000192	0.00248	CcSEcCtD
Quinapril—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000192	0.00248	CcSEcCtD
Quinapril—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000192	0.00248	CcSEcCtD
Quinapril—Shock—Dexamethasone—psoriatic arthritis	0.000191	0.00247	CcSEcCtD
Quinapril—Shock—Betamethasone—psoriatic arthritis	0.000191	0.00247	CcSEcCtD
Quinapril—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000191	0.00246	CcSEcCtD
Quinapril—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00019	0.00246	CcSEcCtD
Quinapril—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00019	0.00246	CcSEcCtD
Quinapril—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00019	0.00245	CcSEcCtD
Quinapril—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00019	0.00245	CcSEcCtD
Quinapril—Tachycardia—Dexamethasone—psoriatic arthritis	0.000189	0.00245	CcSEcCtD
Quinapril—Tachycardia—Betamethasone—psoriatic arthritis	0.000189	0.00245	CcSEcCtD
Quinapril—Angioedema—Prednisone—psoriatic arthritis	0.000189	0.00244	CcSEcCtD
Quinapril—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000188	0.00243	CcSEcCtD
Quinapril—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000188	0.00243	CcSEcCtD
Quinapril—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000188	0.00242	CcSEcCtD
Quinapril—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000188	0.00242	CcSEcCtD
Quinapril—Malaise—Prednisone—psoriatic arthritis	0.000187	0.00241	CcSEcCtD
Quinapril—Vertigo—Prednisone—psoriatic arthritis	0.000186	0.0024	CcSEcCtD
Quinapril—Eye disorder—Methotrexate—psoriatic arthritis	0.000186	0.0024	CcSEcCtD
Quinapril—Syncope—Prednisone—psoriatic arthritis	0.000186	0.0024	CcSEcCtD
Quinapril—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000184	0.00238	CcSEcCtD
Quinapril—Fatigue—Triamcinolone—psoriatic arthritis	0.000184	0.00238	CcSEcCtD
Quinapril—Fatigue—Methylprednisolone—psoriatic arthritis	0.000184	0.00238	CcSEcCtD
Quinapril—Loss of consciousness—Prednisone—psoriatic arthritis	0.000182	0.00235	CcSEcCtD
Quinapril—Angiopathy—Methotrexate—psoriatic arthritis	0.00018	0.00233	CcSEcCtD
Quinapril—Immune system disorder—Methotrexate—psoriatic arthritis	0.00018	0.00232	CcSEcCtD
Quinapril—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000179	0.00231	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000177	0.00228	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000177	0.00228	CcSEcCtD
Quinapril—Myalgia—Prednisone—psoriatic arthritis	0.000176	0.00228	CcSEcCtD
Quinapril—Arthralgia—Prednisone—psoriatic arthritis	0.000176	0.00228	CcSEcCtD
Quinapril—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000176	0.00228	CcSEcCtD
Quinapril—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000176	0.00227	CcSEcCtD
Quinapril—Alopecia—Methotrexate—psoriatic arthritis	0.000176	0.00227	CcSEcCtD
Quinapril—Insomnia—Dexamethasone—psoriatic arthritis	0.000175	0.00227	CcSEcCtD
Quinapril—Insomnia—Betamethasone—psoriatic arthritis	0.000175	0.00227	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000175	0.00226	CcSEcCtD
Quinapril—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000174	0.00225	CcSEcCtD
Quinapril—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000174	0.00225	CcSEcCtD
Quinapril—Paraesthesia—Betamethasone—psoriatic arthritis	0.000174	0.00225	CcSEcCtD
Quinapril—Discomfort—Prednisone—psoriatic arthritis	0.000174	0.00225	CcSEcCtD
Quinapril—Mental disorder—Methotrexate—psoriatic arthritis	0.000174	0.00225	CcSEcCtD
Quinapril—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000171	0.00221	CcSEcCtD
Quinapril—Dyspepsia—Betamethasone—psoriatic arthritis	0.000171	0.00221	CcSEcCtD
Quinapril—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000169	0.00218	CcSEcCtD
Quinapril—Oedema—Prednisone—psoriatic arthritis	0.000169	0.00218	CcSEcCtD
Quinapril—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000169	0.00218	CcSEcCtD
Quinapril—Infection—Prednisone—psoriatic arthritis	0.000168	0.00217	CcSEcCtD
Quinapril—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000168	0.00216	CcSEcCtD
Quinapril—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000168	0.00216	CcSEcCtD
Quinapril—Back pain—Methotrexate—psoriatic arthritis	0.000167	0.00216	CcSEcCtD
Quinapril—Fatigue—Betamethasone—psoriatic arthritis	0.000167	0.00216	CcSEcCtD
Quinapril—Fatigue—Dexamethasone—psoriatic arthritis	0.000167	0.00216	CcSEcCtD
Quinapril—Shock—Prednisone—psoriatic arthritis	0.000166	0.00215	CcSEcCtD
Quinapril—Nervous system disorder—Prednisone—psoriatic arthritis	0.000166	0.00214	CcSEcCtD
Quinapril—Tachycardia—Prednisone—psoriatic arthritis	0.000165	0.00213	CcSEcCtD
Quinapril—Skin disorder—Prednisone—psoriatic arthritis	0.000164	0.00212	CcSEcCtD
Quinapril—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000163	0.00211	CcSEcCtD
Quinapril—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000161	0.00207	CcSEcCtD
Quinapril—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00016	0.00207	CcSEcCtD
Quinapril—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00016	0.00207	CcSEcCtD
Quinapril—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000159	0.00205	CcSEcCtD
Quinapril—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000159	0.00205	CcSEcCtD
Quinapril—Malaise—Methotrexate—psoriatic arthritis	0.000156	0.00202	CcSEcCtD
Quinapril—Vertigo—Methotrexate—psoriatic arthritis	0.000155	0.00201	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000154	0.00199	CcSEcCtD
Quinapril—Dizziness—Prednisolone—psoriatic arthritis	0.000154	0.00199	CcSEcCtD
Quinapril—Asthenia—Triamcinolone—psoriatic arthritis	0.000153	0.00198	CcSEcCtD
Quinapril—Abdominal pain—Betamethasone—psoriatic arthritis	0.000153	0.00198	CcSEcCtD
Quinapril—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000153	0.00198	CcSEcCtD
Quinapril—Asthenia—Methylprednisolone—psoriatic arthritis	0.000153	0.00198	CcSEcCtD
Quinapril—Insomnia—Prednisone—psoriatic arthritis	0.000153	0.00197	CcSEcCtD
Quinapril—Paraesthesia—Prednisone—psoriatic arthritis	0.000152	0.00196	CcSEcCtD
Quinapril—Pruritus—Triamcinolone—psoriatic arthritis	0.000151	0.00195	CcSEcCtD
Quinapril—Cough—Methotrexate—psoriatic arthritis	0.000151	0.00195	CcSEcCtD
Quinapril—Pruritus—Methylprednisolone—psoriatic arthritis	0.000151	0.00195	CcSEcCtD
Quinapril—Dyspepsia—Prednisone—psoriatic arthritis	0.000149	0.00192	CcSEcCtD
Quinapril—Chest pain—Methotrexate—psoriatic arthritis	0.000147	0.0019	CcSEcCtD
Quinapril—Arthralgia—Methotrexate—psoriatic arthritis	0.000147	0.0019	CcSEcCtD
Quinapril—Myalgia—Methotrexate—psoriatic arthritis	0.000147	0.0019	CcSEcCtD
Quinapril—Rash—Prednisolone—psoriatic arthritis	0.000147	0.00189	CcSEcCtD
Quinapril—Dermatitis—Prednisolone—psoriatic arthritis	0.000146	0.00189	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000146	0.00189	CcSEcCtD
Quinapril—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000146	0.00189	CcSEcCtD
Quinapril—Fatigue—Prednisone—psoriatic arthritis	0.000146	0.00188	CcSEcCtD
Quinapril—Headache—Prednisolone—psoriatic arthritis	0.000146	0.00188	CcSEcCtD
Quinapril—Discomfort—Methotrexate—psoriatic arthritis	0.000146	0.00188	CcSEcCtD
Quinapril—Constipation—Prednisone—psoriatic arthritis	0.000145	0.00187	CcSEcCtD
Quinapril—Dizziness—Triamcinolone—psoriatic arthritis	0.000141	0.00183	CcSEcCtD
Quinapril—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000141	0.00182	CcSEcCtD
Quinapril—Dizziness—Methylprednisolone—psoriatic arthritis	0.000141	0.00182	CcSEcCtD
Quinapril—Infection—Methotrexate—psoriatic arthritis	0.00014	0.00181	CcSEcCtD
Quinapril—Feeling abnormal—Prednisone—psoriatic arthritis	0.000139	0.0018	CcSEcCtD
Quinapril—Asthenia—Betamethasone—psoriatic arthritis	0.000139	0.0018	CcSEcCtD
Quinapril—Asthenia—Dexamethasone—psoriatic arthritis	0.000139	0.0018	CcSEcCtD
Quinapril—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000138	0.00179	CcSEcCtD
Quinapril—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000138	0.00179	CcSEcCtD
Quinapril—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000138	0.00179	CcSEcCtD
Quinapril—Nausea—Prednisolone—psoriatic arthritis	0.000138	0.00178	CcSEcCtD
Quinapril—Pruritus—Dexamethasone—psoriatic arthritis	0.000137	0.00177	CcSEcCtD
Quinapril—Pruritus—Betamethasone—psoriatic arthritis	0.000137	0.00177	CcSEcCtD
Quinapril—Skin disorder—Methotrexate—psoriatic arthritis	0.000137	0.00177	CcSEcCtD
Quinapril—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000137	0.00176	CcSEcCtD
Quinapril—Vomiting—Triamcinolone—psoriatic arthritis	0.000136	0.00176	CcSEcCtD
Quinapril—Vomiting—Methylprednisolone—psoriatic arthritis	0.000136	0.00175	CcSEcCtD
Quinapril—Rash—Triamcinolone—psoriatic arthritis	0.000135	0.00174	CcSEcCtD
Quinapril—Dermatitis—Triamcinolone—psoriatic arthritis	0.000135	0.00174	CcSEcCtD
Quinapril—Rash—Methylprednisolone—psoriatic arthritis	0.000135	0.00174	CcSEcCtD
Quinapril—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000134	0.00174	CcSEcCtD
Quinapril—Headache—Triamcinolone—psoriatic arthritis	0.000134	0.00173	CcSEcCtD
Quinapril—Headache—Methylprednisolone—psoriatic arthritis	0.000134	0.00173	CcSEcCtD
Quinapril—Abdominal pain—Prednisone—psoriatic arthritis	0.000134	0.00173	CcSEcCtD
Quinapril—Diarrhoea—Betamethasone—psoriatic arthritis	0.000133	0.00172	CcSEcCtD
Quinapril—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000133	0.00172	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000129	0.00166	CcSEcCtD
Quinapril—Dizziness—Betamethasone—psoriatic arthritis	0.000128	0.00166	CcSEcCtD
Quinapril—Dizziness—Dexamethasone—psoriatic arthritis	0.000128	0.00166	CcSEcCtD
Quinapril—Insomnia—Methotrexate—psoriatic arthritis	0.000128	0.00165	CcSEcCtD
Quinapril—Nausea—Triamcinolone—psoriatic arthritis	0.000127	0.00164	CcSEcCtD
Quinapril—Paraesthesia—Methotrexate—psoriatic arthritis	0.000127	0.00164	CcSEcCtD
Quinapril—Nausea—Methylprednisolone—psoriatic arthritis	0.000127	0.00164	CcSEcCtD
Quinapril—Dyspnoea—Methotrexate—psoriatic arthritis	0.000126	0.00163	CcSEcCtD
Quinapril—Somnolence—Methotrexate—psoriatic arthritis	0.000126	0.00162	CcSEcCtD
Quinapril—Dyspepsia—Methotrexate—psoriatic arthritis	0.000124	0.00161	CcSEcCtD
Quinapril—Vomiting—Dexamethasone—psoriatic arthritis	0.000123	0.00159	CcSEcCtD
Quinapril—Vomiting—Betamethasone—psoriatic arthritis	0.000123	0.00159	CcSEcCtD
Quinapril—Rash—Dexamethasone—psoriatic arthritis	0.000122	0.00158	CcSEcCtD
Quinapril—Rash—Betamethasone—psoriatic arthritis	0.000122	0.00158	CcSEcCtD
Quinapril—Dermatitis—Dexamethasone—psoriatic arthritis	0.000122	0.00158	CcSEcCtD
Quinapril—Dermatitis—Betamethasone—psoriatic arthritis	0.000122	0.00158	CcSEcCtD
Quinapril—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000122	0.00158	CcSEcCtD
Quinapril—Fatigue—Methotrexate—psoriatic arthritis	0.000122	0.00157	CcSEcCtD
Quinapril—Headache—Betamethasone—psoriatic arthritis	0.000122	0.00157	CcSEcCtD
Quinapril—Headache—Dexamethasone—psoriatic arthritis	0.000122	0.00157	CcSEcCtD
Quinapril—Asthenia—Prednisone—psoriatic arthritis	0.000121	0.00157	CcSEcCtD
Quinapril—Pruritus—Prednisone—psoriatic arthritis	0.00012	0.00154	CcSEcCtD
Quinapril—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000116	0.0015	CcSEcCtD
Quinapril—Diarrhoea—Prednisone—psoriatic arthritis	0.000116	0.00149	CcSEcCtD
Quinapril—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000115	0.00149	CcSEcCtD
Quinapril—Nausea—Betamethasone—psoriatic arthritis	0.000115	0.00149	CcSEcCtD
Quinapril—Nausea—Dexamethasone—psoriatic arthritis	0.000115	0.00149	CcSEcCtD
Quinapril—Dizziness—Prednisone—psoriatic arthritis	0.000112	0.00144	CcSEcCtD
Quinapril—Abdominal pain—Methotrexate—psoriatic arthritis	0.000112	0.00144	CcSEcCtD
Quinapril—Vomiting—Prednisone—psoriatic arthritis	0.000107	0.00139	CcSEcCtD
Quinapril—Rash—Prednisone—psoriatic arthritis	0.000107	0.00138	CcSEcCtD
Quinapril—Dermatitis—Prednisone—psoriatic arthritis	0.000106	0.00138	CcSEcCtD
Quinapril—Headache—Prednisone—psoriatic arthritis	0.000106	0.00137	CcSEcCtD
Quinapril—Asthenia—Methotrexate—psoriatic arthritis	0.000101	0.00131	CcSEcCtD
Quinapril—Nausea—Prednisone—psoriatic arthritis	0.0001	0.0013	CcSEcCtD
Quinapril—Pruritus—Methotrexate—psoriatic arthritis	9.99e-05	0.00129	CcSEcCtD
Quinapril—Diarrhoea—Methotrexate—psoriatic arthritis	9.66e-05	0.00125	CcSEcCtD
Quinapril—Dizziness—Methotrexate—psoriatic arthritis	9.34e-05	0.00121	CcSEcCtD
Quinapril—Vomiting—Methotrexate—psoriatic arthritis	8.98e-05	0.00116	CcSEcCtD
Quinapril—Rash—Methotrexate—psoriatic arthritis	8.9e-05	0.00115	CcSEcCtD
Quinapril—Dermatitis—Methotrexate—psoriatic arthritis	8.9e-05	0.00115	CcSEcCtD
Quinapril—Headache—Methotrexate—psoriatic arthritis	8.85e-05	0.00114	CcSEcCtD
Quinapril—Nausea—Methotrexate—psoriatic arthritis	8.39e-05	0.00108	CcSEcCtD
